Circulating tumor DNA (ctDNA) predicts prognosis in triple-negative breast cancer patients: A systematic review

被引：0
|
作者：
Lokanata, Edellin F. [1 ]
Frandi, Beatrix L. [1 ]
Wijaya, Jeremiah H. [1 ]
Purnomo, Alexander E. [1 ]
Tumiwa, Gabriella H. [1 ]
Lokanata, Michael G. [1 ]
Heriyanto, Rivaldo S. [1 ]
Kurniawan, Andree [2 ]
机构：
[1] Pelita Harapan Univ, Fac Med, Tangerang, Indonesia
[2] Pelita Harapan Univ, Fac Med, Dept Internal Med, Tangerang, Indonesia
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.259
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MO41-2
引用
收藏
页码：S1422 / S1423
页数：2
相关论文
共 50 条
  • [31] Caracterization and prognosis in triple negative breast cancer circulating tumor cells
    Abreu Rodriguez, M.
    Cabezas, P.
    Abalo, A.
    Martinez, N.
    Varela, V.
    Garcia, P.
    Sanchez, L.
    Lopez, R.
    Muinelo-Romay, L.
    CLINICAL & EXPERIMENTAL METASTASIS, 2018, 35 (03) : 215 - 216
  • [32] Prognosis of Patients with Triple-negative Breast Cancer and Brain Metastasis
    Venkitaraman, R.
    Joseph, T.
    Dhadda, A.
    Chaturvedi, A.
    Upadhyay, S.
    CLINICAL ONCOLOGY, 2009, 21 (09) : 729 - 730
  • [33] The Role of miRNAs in the Prognosis of Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis
    Santana, Talita Araujo B. da S.
    Passamai, Larissa de Oliveira
    de Miranda, Felipe Silva
    Borin, Thaiz Ferraz
    Borges, Grasiely Faccin
    Luiz, Wilson Barros
    Campos, Luciene Cristina Gastalho
    DIAGNOSTICS, 2023, 13 (01)
  • [34] Usefulness of assessment of circulating tumor DNA(ctDNA) of cerebrospinal fluid(CSF) samples for early detection of brain metastasis (BrM) in patients with triple-negative breast cancer (TNBC).
    Raimondi, Lucrezia
    Naso, Giuseppe
    Lazzeroni, Rachele
    Di Benedetto, Laura
    Raimondi, Filippo Maria
    Di Rocco, Arianna
    Giaconi, Laura
    Rossi, Luigi
    Spinelli, Gian Paolo
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [35] Mutational characteristics determined using circulating tumor DNA analysis in triple-negative breast cancer patients with distant metastasis
    Rong, Guohua
    Yi, Zongbi
    Ma, Fei
    Guan, Yanfang
    Xu, Yaping
    Li, Lifeng
    Xu, Binghe
    CANCER COMMUNICATIONS, 2020, 40 (12) : 738 - 742
  • [36] Circulating tumor DNA (ctDNA) during and after neoadjuvant chemotherapy and prior to surgery is a powerful prognostic factor in triple-negative breast cancer (TN BC).
    Cavallone, Luca
    Aguilar, Adriana
    Aldamry, Mohammed
    Lafleur, Josiane
    Brousse, Susie
    Lan, Cathy
    Alirezaie, Najmeh
    Bareke, Eric
    Majewski, Jacek
    Pelmus, Manuela
    Ferrario, Cristiano
    Marcus, Elizabeth A.
    Robidoux, Andre
    Discepola, Federico
    Basik, Mark
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [37] A CLDN1-Negative Phenotype Predicts Poor Prognosis in Triple-Negative Breast Cancer
    Ma, Fei
    Ding, Xiaoyan
    Fan, Ying
    Ying, Jianming
    Zheng, Shan
    Lu, Ning
    Xu, Binghe
    PLOS ONE, 2014, 9 (11):
  • [38] A Serum MicroRNA Signature Predicts Tumor Relapse and Survival in Triple-Negative Breast Cancer Patients
    Sahlberg, Kristine Kleivi
    Bottai, Giulia
    Naume, Bjorn
    Burwinkel, Barbara
    Calin, George A.
    Borresen-Dale, Anne-Lise
    Santarpia, Libero
    CLINICAL CANCER RESEARCH, 2015, 21 (05) : 1207 - 1214
  • [39] A Review of Triple-Negative Breast Cancer
    Ismail-Khan, Roohi
    Bui, Marilyn M.
    CANCER CONTROL, 2010, 17 (03) : 173 - 176
  • [40] Adrenomedullin inhibits tumor metastasis and is associated with good prognosis in triple-negative breast cancer patients
    Liu, Li-Li
    Chen, Shi-Lu
    Huang, Yu-Hua
    Yang, Xia
    Wang, Chun-Hua
    He, Jie-Hua
    Yun, Jing-Ping
    Luo, Rong-Zhen
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2020, 12 (03): : 773 - 786
12345